BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Net Tangible Assets

Track Fidelity Select Biotechnology Portfolio's net tangible assets ($2.7B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$2.68B

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Net Tangible Assets History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Net Tangible Assets Comparison

Loading

Fidelity Select Biotechnology Portfolio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

As of the most recent data (October 2023), FBIOX shows a net tangible assets of $2.7B. Scroll down for historical charts and peer comparison views.

Tracking FBIOX's net tangible assets over time shows whether Fidelity Select Biotechnology Portfolio is scaling, shrinking, or reshaping that part of the business. The current reading is $2.7B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Fidelity Select Biotechnology Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $2.7B) with ownership activity and broader fundamentals.